Thursday 11 February 2021

Neurology Devices Market - Trends and Regional Demand By Top Companies

 Market Highlights

According to MRFR analysis, the Global Neurology Devices Market is expected to register a CAGR of 10.2% during the forecast period of 2020 to 2027 and reach USD 21,029.7 Million by 2027.

Neurology devices are used for the treatment of neurological disorders that comprise pathophysiological conditions that affect the brain, spinal cord, and nervous system.

 Get Free Sample @  https://www.marketresearchfuture.com/sample_request/9768

The market for neurology devices is expected to grow at boost due to a surge in the prevalence of the neurological disorder, a growing aging population, increasing adoption of technologically advanced devices, and growing demand for minimally invasive devices. However, high cost and stringent regulatory government regulations are some of the factors expected to hinder the growth of the market.

 The global market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors. As per the statistics of WHO in 2017, around 50 million people all over the world were affected by epilepsy. Additionally, Alzheimer's Research UK stated that over 50.8 million people worldwide were affected by dementia in 2017 and was expected to reach 55 million patients in 2020. Moreover, this number would double every 20 years, reaching 75 million by 2030 and 131.5 million by 2050. These huge prevalence of neurological disorders among the population and rising healthcare expenditure for neurological disorders are driving the growth of the neurology devices market.

 Key Players

 Some of the key players in the global neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc., Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others

 Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the increasing adoption of technological devices, favorable reimbursement scenarios, and the presence of major manufacturers among others. The neurology devices market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European neurology devices market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The neurology devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing geriatric population, the market in Asia-Pacific is expected to be the fastest-growing. The neurology devices market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/neurology-devices-market-9768 

Segmentation

The global neurology devices market has been segmented based on the product, and end user.

Based on product the market is segmented into neurostimulation, Interventional neurology, CSF management, and Neurosurgery devices. Neurostimulation segment accounted for the major market share owing to the increasing prevalence of epilepsy, Parkinson's disease, tremor, dystonia, depression, obsessive-compulsive disorder, Tourette syndrome, chronic pain, and cluster headache. The segment is further bifurcated by spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation.

 

Interventional neurology segment is divided into aneurysm coiling & embolization (embolic coils, flow diversion devices, liquid embolic agents), cerebral balloon angioplasty & stenting (carotid artery stents, filter devices, balloon occlusion devices), neurothrombectomy (clot retriever, suction aspiration devices, snares). Moreover, CSF management is further distributed into the following sub-segments, CSF shunts, and CSF drainage. The neurosurgery devices segment is further sub-segmented into ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips. The segment is expected to grow at the fastest CAGR during the forecast period owing to the increasing demand for non-invasive neurosurgery.

 The market based on end users has been segmented into hospitals & clinics, specialty centers, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Airway Management Market Analysis and Demand by Top Leaders

 Market Highlights

According to MRFR analysis, Airway Management Market is expected to register a CAGR of 5.2% during the forecast period of 2019 to 2025 and is predicted to value USD 1,764.47 Million in 2025.

Download Free sample @ https://www.marketresearchfuture.com/sample_request/8472

Airway management plays an essential role in complex conditions. These devices and procedures are used for providing ventilation to the patients during surgical procedures, respiratory emergencies, and other medical procedures. For instance, lung cancer is the leading cause of death worldwide, with the estimated number of deaths caused by it in the year 2018 was approximately 9.6 million. Airway management has benefits that can resolve complications that may arise during the treatment of lung cancer and related disorders.

However, the low compatibility of airway management devices with patients is likely to hamper the growth of the global airway management market during the forecast period.

Several market players currently dominate the global airway management market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced airway management procedures. The Americas has been branched into North America and Latin America, with the North American market being further divided into the US and Canada.

The airway management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is anticipated to hold the fastest-growing market share owing to the increasing geriatric population and the rising adoption of technological advancements in developing regions. The European airway management market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The airway management market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/airway-management-market-8472

Segmentation

The global airway management market has been segmented based on product type, application, and end user.

The market, based on product type, has been divided into supraglottic, infra-glottic, laryngoscopes, accessories, anesthesia masks, and others. The supraglottic segment is likely to hold the maximum market share in the global airway management market. Supraglottic are further segmented into laryngeal mask, nasopharyngeal, oropharyngeal, others.

On the basis of application, the global airway management market is segmented into general anesthesia, respiratory care, surgery, others. The end user segment of the market consists of surgical centers, hospitals, others. The hospital segment is expected to hold the largest share of the market as these centers are primary locations for the utilization of airway management products and services. As hospitals are primary medical facilities that use airway management devices and services the most. These products and services are used for patients undergoing surgeries, affected by respiratory emergencies and throat-related complications.

Key Players

Some of the key players in the global airway management market are Vyaire Medical(US), Vbm Medizintechnik Gmbh (Germany), Roper Technologies (US) (Verathon Inc.), Sourcemark (US), Salter Labs (US), Ambu A/S. (Denmark), Intersurgical Inc (UK), Medtronic (Ireland), Smiths Group PLC (UK) (Smiths Medical), Teleflex Incorporated (US), and Sunmed (US).

Also Read @ https://www.medgadget.com/2020/07/covid-19-impact-on-airway-management-market-growth-2020-industry-analysis-size-estimation-top-company-share-regional-insights-demand-overview-forecast-to-2025.html 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

Cardiovascular Information System (CVIS) Market Investment Opportunities, Business Revenue, Trends, Opportunities, Demand Forecast, Growth and Impact of COVID-19

 Overview

The global cardiovascular information system (CVIS) market size is poised to reach the valuation of USD 1,343.26 million by 2025, as per the latest report by Market Research Future (MRFR). The market can grow immensely at 8.30% CAGR over the forecast period (2018-2025).

High prevalence of cardiovascular diseases (CVDs) and disorders is the primary driver of the market. As per the 2015 report by the World Health Organization (WHO), nearly 17.7 million died as a result of CVDs. This has triggered the need for advanced systems in hospitals to reduce the mortality rate. In addition, government initiatives to digitize patient data is likely to bode well for the cardiovascular information system (CVIS) market. Implementation of the electronic health records (EHR) system can make it easy for doctors and physicians to lead to faster diagnosis of diseases.

Technological developments in healthcare IT has led to the launch of CVIS platforms which can be accessed remotely. This offers scope for doctors to diagnose and prescribe accurate suggestions to patients. Recent upgrades to CVIS has made it possible for different departments in the cardiology section to share and exchange information on a single platform.

The high costs associated with CVIS which can lead to hesitation towards adoption among hospitals can pose a challenge to the market growth.

Segmentation Analysis

The cardiovascular information system (CVIS) market is segmented by component, deployment, application, and end-user.

By component, software held close to 67.9% share of the CVIS market in 2017, followed by services the second largest market and hardware the least market share. The software segment is expected to reach a valuation of USD 930.65 million by 2025 due to the software being able to provide clinical data to patients and doctors in real-time. Services, on the other hand, can aim to grow at a steady pace by the end of the forecast period due to constant maintenance and upgradation of CVIS to ensure a smooth workflow in clinics and hospitals.

By deployment, web/cloud-based held the largest market share in 2017, while the on-premise segment held second largest share. The web/cloud-based CVIS is projected grow at fastest CAGR during the forecast period due to low capital investment and scalability of operations. In addition, the ease it provides in reporting information and causing minimal clinical efficiencies can lead to its adoption. On the other hand, on-premise segment accounted for the least market share due to high expenses in maintaining servers, software, and hardware.

Among applications, cardiac and peripheral catheterization held 32.4% share in 2017, followed by echocardiography, hemodynamics monitoring, electrophysiology, vascular ultrasound, nuclear cardiology, ECG/stress/Holter management, and others. Cardiac and peripheral catheterization can increase its market share by the end of the forecast period due to its extensive use in early diagnosis and treatment of congenital disorders. On the other hand, echocardiography is predicted to attain second largest share, this can be attributed to its utilization in detecting abnormal heart valves and other heart defects.

Hospitals & clinics was the biggest market end-user in 2017 with a respectable 48.2% share, followed by diagnostic laboratories, cardiac cath labs, and others. Hospitals & clinics can reach a value of USD 640 million by 2025 due to adoption of advanced diagnostic systems for treating CVDs. Diagnostic laboratories generated second largest share for the cardiovascular information system (CVIS) market by 2025. This can be credited to demand by patients for rapid diagnosis solutions.

 

Competitive Analysis

Key vendors in the cardiovascular information system (CVIS) market include Carestream Health (U.S.), Scimage, Inc. (U.S.), Koninklijke Philips N.V. (The Netherlands), Cerner Corporation (U.S.), Epic Systems Corporation (U.S.), Digisonics Inc. (U.S.), Fujifilm Holdings Corporation (Japan), LUMEDX (China), Agfa-Gevaert N.V. (Belgium), IBM Health (U.S.), General Electric Company (U.S.), McKesson Corporation (U.S.), and Siemens Healthineers (Germany).

 

You can also read Here@ https://www.medgadget.com/2019/10/latest-research-on-cardiovascular-information-system-cvis-market-2019-global-industry-size-share-regional-trends-development-strategy-competitor-analysis-opportunities-complete-study.html

 

Regional Analysis

Region-wise, the cardiovascular information system (CVIS) market covers the upcoming trends in Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA). The Americas accounted for 37.6% market share in 2017, followed by Europe, APAC, and MEA.

The Americas CVIS market is expected to reach a valuation of USD 481.04 million by 2025. This can be attributed to sophisticated healthcare infrastructure and adoption of latest systems for streamlining workflow in hospitals. The use of mHealth and big data for detecting CVDs at a preventive stage by clinicians is projected to augur well for the market.

Europe, on the other hand, is predicted to grow at a steady pace due to increased funding by governments and private organizations to improve treatment facilities in cardiology departments in hospitals. Moreover, digitization of patient data is expected to be a positive indicator for the growth of the market.

 

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/cardiovascular-information-system-market-7721

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Near Infrared Imaging Market Driving Factors, Industry Analysis, Investment Feasibility and Trends, Outlook -2023

 

Market Highlights

 

The global near infrared imaging market held a market value of USD 316 million in 2017 and is projected to grow at a CAGR of 12.6% over the forecast period. 

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/7424

 

Near infrared imaging uses near infrared light between 650 and 950 nm to non-invasively examine the concentration and oxygenation of hemoglobin which is used to detect changes induced by brain activity, injury, or disease. Moreover, near infrared imaging is portable and inexpensive device which may boost the market during forecast period.

Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. Moreover, companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.


 Browse Complete Report @ https://www.marketresearchfuture.com/reports/near-infrared-imaging-market-7424

Segmentation

The global near infrared imaging market has been segmented into product type, application, and end user.

By product type, the market has been segmented into devices, reagents, and others. Devices segment is further segmented into near-infrared fluorescence imaging systems and near-infrared bioluminescence imaging systems.

Based on application, the market has been segmented into cancer surgeries, preclinical imaging, plastic/reconstructive surgeries, gastrointestinal surgeries, cardiovascular surgeries, and others. 

The near infrared imaging market, by end user, has been segmented into pharmaceutical & biotechnology companies, hospitals & clinics, research laboratories & academic institutions, and others.

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global near infrared imaging market owing to the growing R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region. 

Europe is expected to hold the second largest position in the global near infrared imaging market owing to the presence of strong academic & research base and availability of funding for research in the European countries. 

Asia Pacific has served an opportunity for developing near infrared imaging market in this region due to increasing demand for the better treatment and devices and increasing prevalence of disease like cardiovascular diseases and cancer.

 The Middle East & Africa has the least share of the global near infrared imaging market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Key Players

Some of the prominent players in the global near infrared imaging market are PerkinElmer, Inc. (US), Li-Cor, Inc. (US), Stryker Corporation (US), Karl Storz Se & Co.Kg (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Medtronic (Ireland), Hamamatsu Photonics K.K., (Japan), Olympus Corporation (Japan), Shimadzu Corporation (Japan), Quest Medical Imaging B.V. (the Netherlands), Mizuho Medical Co., Ltd. (Japan), and others.

Read more @ https://www.marketresearchfuture.com/reports/near-infrared-imaging-market-7424

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: 
sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Analysis on Compression Therapy Market Size, research Report and Forecast

 

Market Highlights

The Global compression therapy market is expected to grow at an approximate CAGR of 5.2% during forecast period, 2018–2023.

Increasing participation of market players is the key factor driving the compression therapy market. For instance, in 2015, SIGVARIS launched diabetic compression socks to provide maximum therapeutic relief for diabetic patients.

Various other factors such as increasing incidence of sports injuries and accidents, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of compression therapy are also expected to propel the growth of the market.

However, low patient compliance for compression garments, adoption of alternative therapies for specific target indications and lack of universally accepted standards for compression products can hinder the market growth over the forecast period.

Regional Analysis

The Americas dominated the global market for compression therapy. This can be attributed to the presence of major market players within the region.

Owing to the rising research and development investment and increasing prevalence venous leg ulcers, European compression therapy market stood second in 2017. According to the 2018 study published in the Burns & Trauma journal, venous ulcers are a common chronic problem in many countries especially in Northern Europe. The overall prevalence of this condition is 1%-3% in the population above 65 years of age.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the data suggested by the Australian Institute of Health and Welfare, Australia spent nearly USD 181 billion on health in 2016–2017.

On the other hand, the Middle East and Africa held least share in the global compression therapy market due to the low per capita income, especially within the African region.

Segmentation

The Global compression therapy market is segmented based on technique, product, application and region.

The Global market for compression therapy, by technique is segmented into static compression therapy and dynamic compression therapy.

The market, by product, is segmented into compression garments, compression pumps and compression braces. The compression garments segment is further classified as compression stockings, compression bandages & wraps and others.

Based on application, the market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment and others.

 

Key Players

Some of the key players in the global compression therapy market are 3M, Medtronic PLC, Bio Compression Systems, Inc., BSN Medical, Medi GmbH & Co. Kg, Paul Hartmann AG, Smith & Nephew PLC., Cardinal Health, Inc., Sigvaris, Sanyleg S.R.L., Tactile Medical, Convatec Inc., DJO Global Inc., Getinge AB, Juzo and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/compression-therapy-market-7185

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: 
sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Global Trend on Fabry Disease Market Size, Demand, Growth by 2023

 Market Highlights:

The Global Fabry Disease Market is expected to grow at a CAGR of 6.8% during the forecast period. Technological advancements, strong pipeline, advancements in healthcare facilities, and favorable funding policies are expected to drive the market growth over the forecast period. Owing to the increasing awareness about Fabry disease, new and existing market players are coming up with better treatment approaches. For instance, in 2018, 2018, Amicus Therapeutics launched Galafold capsules 123mg for the treatment of patients aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation.

However, diverse range of symptoms, and related complications can restrain the market growth over the assessment period.

Regional Analysis:

Geographically, the Americas is expected to dominate the global market owing to the increasing technological advancements and rising research and development activities. Gastrointestinal manifestations such as abdominal pain, diarrhea and nausea are significant burden in a patient with Fabry disease. So, for the advanced treatment of these patients SmartPill testing procedure is developed to gain additional understanding of Fabry disease manifestation via motility abnormalities in order to improve symptom targeted therapy. This device is currently under clinical trial and the sponsor of this study is Massachusetts General Hospital.

Europe is expected to hold the second largest market share. Nearly 2.2 in 10,000 people in the European Union (EU) are affected with Fabry disease and Fabrazyme (agalsidase beta), Galafold (migalastat) and Replagal (agalsidase alfa) are the three authorized drugs used for the treatment of Fabry disease.

Asia-Pacific is expected to be the fastest growing market owing to the improving healthcare infrastructure.

Moreover, the Middle East and Africa region is expected to hold the least market share in the global Fabry disease market.

Segmentation:

The Global Fabry Disease Market has been segmented into type, diagnosis & treatment and end user.

the market, on the basis of type, has been segmented into type-1 and type-2. The type-2 Fabry disease holds the major market share due to the high occurrence of type-2 Fabry disease i.e. 1 in 1,500 to 4000 males.

The market, by diagnosis & treatment, has been segmented into diagnosis and treatment. The diagnosis segment is further classified as blood test, urine test, thyroid test, lung function test, and imaging. The imaging segment includes electrocardiogram (EKG), echocardiogram, brain MRI, CT scan and others. The treatment segment is further classified as enzyme replacement therapy, gene therapy, pharmaceutical formulations containing agalsidase alfa, analgesics, anticonvulsants, nonsteroidal anti-inflammatory drugs (NSAIDs), and others.

The market, by end user, has been segmented into hospitals & clinics, diagnostic centers, research & academic institutes, and others.

Key Players:

Some of the prominent players in the global Fabry disease market are Amgen Inc., Amicus Therapeutics, Inc., AVROBIO, Inc., Idorsia Pharmaceuticals Ltd, Protalix, Bristol-Myers Squibb Company, GlaxoSmithKline, iBio, Inc., Neuraltus Pharmaceuticals, Inc., Novartis AG, Pfizer Inc., Sanofi, Shire, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/fabry-disease-market-7064

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: 
sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Wednesday 10 February 2021

Market Report : Animal Genetics Market Size, Growth Factors, Demand and Research Report

 

Market Highlights:

The Animal Genetics Market is expected to witness tremendous growth owing to as increased adoption of genetic services to prevent genetic diseases and business loss, and rising acceptance of advanced genetic technologies. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for specific breeding programs for breeds with inferior economic performance, and economic sustainability in local breeds is likely to curb the market growth during the forecast period.
Get Free Sample!!
https://www.marketresearchfuture.com/sample_request/7004  
Regional Analysis:
The Americas is the largest in the market owing to the high acceptance of animal genetics in research, the development in research expenditure along with the increasing acquisition by the market players are also accountable for the growth of the animal genetics market. For instance, in 2018, Neogen completed the acquisition of Livestock Genetic Services, a firm that specializes in genetic evaluations and data management for cattle-breeding organizations. This strategy enhances the company’s in-house genetic evaluation capabilities and further expands the company’s global network of animal genomics laboratories.

The European region is the second largest animal genetics market over the forecast period due to high consciousness about animal wellbeing coupled with increased expenditure on veterinary services in the region. As per a report by the European Pet Food Industry Federation, more than 75 million households in Europe own a pet.

The Asia Pacific region is likely to develop at the uppermost CAGR for the animal genetics market in the years to come. Moreover, the rising veterinary care services both at the veterinary hospital and at community level are expected to influence the market in a positive way.

The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, there has been an increasing demand for test accuracy and consistency among end-users and the government in this region that is enhancing the adoption of animal genetic technology in this region.
Segmentation:
The Global Animal Genetics Market is segmented into animal genetic products, services, and end-user. The Animal Genetics Market, by animal genetic products, the market is segmented into genetic materials and live animals. The live animals are further bifurcated into poultry, bovine, porcine, canine and others. The genetic materials are sub-segmented into semen and embryo. On the basis of services, the animal genetics market is bifurcated into genetic disease tests, DNA typing, gene trait tests, and others. On the basis of end-user, the market is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others


Browse Complete Report @  https://www.marketresearchfuture.com/reports/animal-genetics-market-7004

Key Players:
Some of the key players in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), EW Group (Germany), Groupe Grimaud (France), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), Envigo (US) Hendrix Genetics BV (The Netherland), Animal Genetics (US), Alta Genetics (US), vetGen (US), and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: 
sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Bone Growth Stimulator Market Trends, NEWS, Demand anD Growth Factors

 Market Highlights:

Global Bone Growth Stimulator Market held a market value of USD 1,213 million in 2017 and is projected to grow at a CAGR of 5.86% over the forecast period.Bone Growth Stimulators are devices that are used to boost the healing process during the treatment of the ailments such as spinal fixation, orthopedic fixation, bone fractures and many other. Bone Growth Stimulator enhances the healing process by stimulating the production of new cells, which will allow your fracture to heal considerably faster. This is a perfect approach when you want to get back on your feet quickly. Besides that, one major advantage is surgical operation can be prevented when this approach is used during treatment. Bone growth stimulators have revolutionized the treatment of bone fractures and spinal fusions and are becoming an important tool in the healing process. All these factors contribute to the growth of the bone growth stimulator market.

 

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6962

 

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global bone growth stimulator market owing to the rising prevalence of the orthopaedic and spinal ailments such as bone fractures, and spinal damage among others. The development of the better therapeutic approaches and advanced treatment procedures have affected the growth of the American market in a positive way. Moreover, increasing rate of the spinal fusion procedures, growing patient population for the orthopaedic fixation procedures, high awareness among American population, high disposable income, are some of the many factors that drive the growth of the bone growth stimulator market in this region.

 

Europe is expected to hold the second largest market share in the global bone growth stimulator market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the bone growth stimulator market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East and Africa region is anticipated to show minor growth opportunities in the bone growth stimulator market during the forecast period.

 

Segmentation:

Global Bone Growth Stimulator Market has been segmented into product, application and end user.Based on products, the market has been segmented into, bone growth stimulation devices, bone morphogenetic proteins, platelet-rich plasma, and others. The bone growth stimulation devices segment is further segmented into, external bone growth stimulators, implanted bone growth stimulators, and ultrasonic bone growth stimulators among which external bone growth stimulators include pulsed electromagnetic field devices, capacitive coupling devices, and combined magnetic field devices. The bone growth stimulation devices segment is expected to account for the largest share in the global bone growth stimulator market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better patient compliance as compared to other techniques.

 

On the basis of application, the market has been segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral and maxillofacial surgeries, and other. The spinal fusion surgeries segment is expected to account for the largest share in the global bone growth stimulator market in 2017.On the basis of end users, the market has been segmented into hospitals & clinics, home care, academic and research institutes, and others. The hospitals & clinics segment is expected to account for the largest share in the global bone growth stimulator market in 2017. At the same time, the increasing establishments of the home care services in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.Based on the regions, the market for bone growth stimulator is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bone growth stimulator market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.

 

European bone growth stimulator market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The bone growth stimulator market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bone growth stimulator market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.

 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/bone-growth-stimulator-market-6962

 

Key Players:

Some of the prominent players in the global bone growth stimulator market are Arthrex, Inc., Bioventus LLC, Depuy Synthes (A Subsidiary of Johnson & Johnson), DJO Finance LLC, Harvest Technologies (A Terumo BCT Company), Isto Biologics, Medtronic PLC, Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc..

 

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com .

Trends on Cannula Market Size, Global Analysis and Regional Growth

 

Market Highlights:

The Global Cannula Market is anticipated to hold a market value of USD 113 million in the year 2017 and is expected to grow at a CAGR of 6.7% during the forecast period. Cannula is a thin tube entered into a vein or body cavity in order to administer medication or to drain off fluid or to insert some surgical instrument.

 

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6937

 

Rising number of surgeries, advancements in healthcare facilities and large pool of geriatric population are expected to drive the market growth over the forecast period. According to a report published by the Population Reference Bureau in January 2016, population in America aged 65 years and more is estimated to become 98 million by 2060 from 46 million currently. However, uncertain government regulations regarding medical devices can restrain the market growth over the assessment period.

 

Regional Analysis:

 

Geographically, the Americas is expected to dominate the global market owing to the easy availability of advanced healthcare infrastructure and rising awareness about minimally invasive surgeries. According to a report published by the American Society of Plastic Surgeons, in the US, total cosmetic minimally-invasive procedures performed were 15,714,118 in 2017. This number was 2% more as compared to 2016. Europe is expected to hold the second largest position in the global market owing to the rising number of cardiovascular surgeries. Asia-Pacific is expected to be the fastest growing market owing to the presence of a large patient pool and increasing geriatric population requiring surgeries. According to an article published by the Asian Development Bank in January 2017, Asia’s elderly population is estimated to reach nearly 923 million by the middle of the century. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

 

Segmentation:

 

The global cannula market has been segmented into product, material, application and end user.The market, on the basis of product, has been segmented into cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas and others.

 

The global market, on the basis of material, has been segmented into plastic (PVC), silicone and metal (stainless steel). The plastic (PVC) cannula are expected to hold the largest market share owing to its extensive use in general surgeries. The silicone cannula are expected to grow at the fastest CAGR owing to its increasing usage in oxygen therapies and their flexible & soft nature.

 

The global cannula market, by application, has been segmented into cardiovascular surgery, oxygen therapy, general surgery, cosmetic/plastic surgery, orthopedic surgery and others. The global market, on the basis of end users, has been segmented into hospitals, ambulatory surgical centers and others.

 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/cannula-market-6937

 

Key Players:

 

Some of the prominent players in the global cannula market are Medtronic, Edwards Lifesciences Corporation, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Smith & Nephew, CONMED Corporation, Smiths Medical, Teleflex Incorporated, Boston Scientific Corporation, McKesson Medical-Surgical Inc., Harsoria Healthcare Pvt. Ltd., ISPG Inc., ILIFE MEDICAL DEVICES PRIVATE LIMITED (INDIA), Denex International, BD and Others.

 

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Key Trends on Cardiac Monitoring and Cardiac Rhythm Management Device Market Size, report, News and Demand

 Market Highlights

Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the cardiac monitoring and cardiac rhythm management device market. Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6332

Regional Analysis

The market in the Americas is expected to dominate the global cardiac monitoring and cardiac rhythm management device market during the forecast period owing to the increasing prevalence of chronic kidney diseases along with the growing geriatric population and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector, coupled with increasing research and development. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological developments, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities. The market in the Middle East and Africa is likely to account for the smallest share of the global cardiac monitoring and cardiac rhythm management device market. The market growth in this region can be attributed to the increasing healthcare expenditure and low-cost cardiac monitoring devices.

Segmentation

The global cardiac monitoring and cardiac rhythm management device market has been segmented on the basis of types and end-users.

 

Based on type, the cardiac monitoring and cardiac rhythm management device market is segmented into types of cardiac devices, types of cardiac monitoring devices, and types of cardiac rhythm management devices. Further, the types of cardiac devices are segmented into pacemaker, biventricular pacemaker, implantable cardioverter defibrillator, implantable cardiac, and loop recorder. Based on types of cardiac monitoring devices, the market is further segmented into electrocardiogram (ECG), Holter monitor, event monitor, implantable loop recorder, and cardiac output monitoring devices. Electrocardiogram (ECG) is further sub-segmented into telelectro-cardiogram, wireless ECG, and lead ECG test. Based on types of cardiac rhythm management devices, the market is segmented into defibrillators,  pacemakers, and cardiac resynchronization therapy devices. Defibrillators are further sub-segmented into implantable defibrillators and external defibrillators. Based on end-user the market is segmented into hospitals, ambulatory surgeries, and others.

Key Players

Some of the key players in the global cardiac monitoring and cardiac rhythm management device market are  Abiomed, Berlin Hearth, Brotionik SE and Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric(GE), Hill Rom Services Inc, Jarvik Hearth. Inc, Koninklijke Philips N.V, LivaNova plc, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc, Schiller, and Abbott.

 

Access Report @ https://www.marketresearchfuture.com/reports/cardiac-monitoring-advance-technologies-global-market-6332

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: 
sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Augmented Reality in Healthcare Market Size, Global Growth, News and Demand

 Market Highlights

The global augmented reality in the healthcare market is spanned across Americas, Europe, Asia Pacific, and Rest of world. North America dominates the augmented reality in healthcare market due to growing adoption of artificial reality and internet of things, which is propelling the market growth in this region to a large extent. On January 12, 2017, Philips announced its new and innovative augmented-reality in surgical navigation technology, designed for the image-guided spine, cranial and trauma surgery. This augmented-reality is the combination of 3D X-ray imaging, optical imaging, and others.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/5236

The North American region is experiencing a higher demand due to growing adoption of augmented reality technology and the increasing need to reduce the healthcare cost in this region is propelling the growth of this market to a large extent. The prominent companies such Augmedix (U.S.), Oculus VR (U.S.), CAE Healthcare (U.S.), Philips Healthcare (Netherlands & U.S.), 3D Systems (U.S.), are providing augmented reality in healthcare solutions in the market. These major players are investing in offering augmented reality in healthcare solution across the world.

The global augmented reality in the healthcare market is expected to reach USD ~ 1.32 billion at a CAGR of over 23% by the end of the forecast period.

Taste the market data and market information presented through more than 30 market data tables and figures spread over 100 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “The Global Augmented reality in healthcare Market Research Report -Forecast to 2023”.

Global Augmented Reality in Healthcare Market Segmentation

The global augmented reality in the healthcare market is segmented into component, device type, application, and region. The component is further segmented into hardware, software, and others. Further, the hardware segment is sub-segmented into sensors, displays and projectors, position tracker, cameras, and others. The device type segment is sub-segmented into head-mounted display, handheld device, and others. The application segment is further sub-segmented into fitness management, medical training and education and others. The market is spanned across regions including North America, Europe, Asia Pacific, and rest of the world.

The prominent players in the global augmented reality in healthcare market are Google LLC. (U.S.), Microsoft Corporation (U.S.), DAQRI (U.S.), Mindmaze (Switzerland), Wikitude GmbH (Austria), Medical Realities (U.K), Atheer (U.S.), Augmedix (U.S.), Oculus VR (U.S.), CAE Healthcare (U.S.), Philips Healthcare (Netherlands & U.S.), 3D Systems (U.S.), Blippar (U.K), VirtaMed (Switzerland), HTC (Taiwan), Siemens Healthineers (Germany), Magic Leap, Inc. (U.S.), and Osterhout Design Group (U.S.) and Virtually Better (U.S.), among others.

Market Research Analysis:

The global augmented reality in healthcare market consists of the Americas, Europe, Asia Pacific, and Rest of world. North America is dominating the global augmented reality in the healthcare market. The augmented reality in the healthcare market is witnessing a high growth due to increasing demand for medical services via which the patients are being treated, propelling the market growth of augmented reality in healthcare in this region. Europe is projected to hold the second largest share of the augmented reality in healthcare market during the forecast period as the sensors are widely used in healthcare. For instance, multi-sensory learning is being considered to be very beneficial in transmitting information in medical sector. Asia Pacific is expected to witness the highest CAGR in the coming years.

ACCESS REPORT DETAILS @ https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: 
sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/